It is reported that the suppression of PIAS1 abolished the ability of arsenic trioxide, an effective treatment of acute promyelocytic leukemia (APL), to trigger apoptosis in APL cells [16]. This evidence concerns the gene PIAS1 and acute promyelocytic leukemia.